ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 50 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2018. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $331 | -54.9% | 150,000 | -40.0% | 0.00% | -50.0% |
| Q1 2023 | $734 | +29.9% | 250,000 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $565 | -99.9% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $485,000 | -25.8% | 250,000 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $654,000 | -12.2% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $745,000 | -18.7% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $916,000 | -13.8% | 250,000 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,063,000 | +39.0% | 250,000 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $765,000 | -0.1% | 250,000 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $766,000 | -14.1% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $892,000 | +16.4% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $766,000 | +493.8% | 250,000 | +338.6% | 0.00% | +200.0% |
| Q2 2019 | $129,000 | -58.5% | 57,000 | +65.2% | 0.00% | -50.0% |
| Q1 2019 | $311,000 | +196.2% | 34,500 | +21.1% | 0.00% | +100.0% |
| Q4 2018 | $105,000 | -66.2% | 28,500 | -17.4% | 0.00% | -50.0% |
| Q3 2018 | $311,000 | +22.4% | 34,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $254,000 | +46.0% | 34,500 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $174,000 | – | 34,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
| RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
| COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
| Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
| Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
| 683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
| Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
| Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
| Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |